BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27119507)

  • 21. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene.
    Menendez P; Catalina P; Rodríguez R; Melen GJ; Bueno C; Arriero M; García-Sánchez F; Lassaletta A; García-Sanz R; García-Castro J
    J Exp Med; 2009 Dec; 206(13):3131-41. PubMed ID: 19995953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficiency of homologous recombination and non-homologous end joining systems in repairing double-strand breaks during cell cycle progression.
    Bee L; Fabris S; Cherubini R; Mognato M; Celotti L
    PLoS One; 2013; 8(7):e69061. PubMed ID: 23874869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the DNA repair pathways utilised by acute lymphoblastic leukaemia cells following daunorubicin treatment.
    Al-Aamri HM; Irving HR; Meehan-Andrews T; Bradley C
    BMC Res Notes; 2019 Sep; 12(1):625. PubMed ID: 31551083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of Chromatin Dynamics by Hypotonic Stress Suppresses HR and Shifts DSB Processing to Error-Prone SSA.
    Krieger LM; Mladenov E; Soni A; Demond M; Stuschke M; Iliakis G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.
    Bueno C; Ayllón V; Montes R; Navarro-Montero O; Ramos-Mejia V; Real PJ; Romero-Moya D; Araúzo-Bravo MJ; Menendez P
    Blood; 2013 May; 121(19):3867-78, S1-3. PubMed ID: 23479570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.
    Sanjuan-Pla A; Bueno C; Prieto C; Acha P; Stam RW; Marschalek R; Menéndez P
    Blood; 2015 Dec; 126(25):2676-85. PubMed ID: 26463423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice.
    Tamai H; Miyake K; Yamaguchi H; Takatori M; Dan K; Inokuchi K; Shimada T
    Blood; 2012 Jan; 119(1):64-71. PubMed ID: 22025528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.
    Agraz-Doblas A; Bueno C; Bashford-Rogers R; Roy A; Schneider P; Bardini M; Ballerini P; Cazzaniga G; Moreno T; Revilla C; Gut M; Valsecchi MG; Roberts I; Pieters R; De Lorenzo P; Varela I; Menendez P; Stam RW
    Haematologica; 2019 Jun; 104(6):1176-1188. PubMed ID: 30679323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
    Malouf C; Antunes ETB; O'Dwyer M; Jakobczyk H; Sahm F; Landua SL; Anderson RA; Soufi A; Halsey C; Ottersbach K
    Blood; 2021 Nov; 138(21):2066-2092. PubMed ID: 34111240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia.
    Lin S; Luo RT; Ptasinska A; Kerry J; Assi SA; Wunderlich M; Imamura T; Kaberlein JJ; Rayes A; Althoff MJ; Anastasi J; O'Brien MM; Meetei AR; Milne TA; Bonifer C; Mulloy JC; Thirman MJ
    Cancer Cell; 2016 Nov; 30(5):737-749. PubMed ID: 27846391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression.
    Huang W; Fang K; Chen TQ; Zeng ZC; Sun YM; Han C; Sun LY; Chen ZH; Yang QQ; Pan Q; Luo XQ; Wang WT; Chen YQ
    J Hematol Oncol; 2019 Oct; 12(1):103. PubMed ID: 31623653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors.
    Chen YP; Lin HJ; Chen JS; Tsai MY; Hsieh HP; Chang JY; Chen NF; Chang KC; Huang WT; Su WC; Yang ST; Chang WC; Hung LY; Chen TY
    Int J Cancer; 2014 Aug; 135(3):751-62. PubMed ID: 24382688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11).
    Wilhelm A; Marschalek R
    Oncogene; 2021 Oct; 40(42):6093-6102. PubMed ID: 34489550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein.
    Caslini C; Serna A; Rossi V; Introna M; Biondi A
    Leukemia; 2004 Jun; 18(6):1064-71. PubMed ID: 14990976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
    Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F
    Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
    Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
    Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34+ HSPC But Is Insufficient to Initiate Leukemia.
    Prieto C; Stam RW; Agraz-Doblas A; Ballerini P; Camos M; Castaño J; Marschalek R; Bursen A; Varela I; Bueno C; Menendez P
    Cancer Res; 2016 Apr; 76(8):2478-89. PubMed ID: 26837759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of MLL/AF4 transgenic mice with the phenotype of lymphoblastic leukemia or lymphoma.
    Tamai H; Inokuchi K
    J Nippon Med Sch; 2013; 80(5):326-7. PubMed ID: 24189350
    [No Abstract]   [Full Text] [Related]  

  • 39. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells.
    Moneypenny CG; Shao J; Song Y; Gallagher EP
    Carcinogenesis; 2006 Apr; 27(4):874-81. PubMed ID: 16377807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
    Atkin ND; Raimer HM; Wang Z; Zang C; Wang YH
    Genes Chromosomes Cancer; 2021 Dec; 60(12):808-821. PubMed ID: 34405474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.